𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Immune responses to late booster doses of hepatitis B vaccine

✍ Scribed by Dr. Wolfgang Jilg; Marion Schmidt; Friedrich Deinhardt

Publisher
John Wiley and Sons
Year
1985
Tongue
English
Weight
295 KB
Volume
17
Category
Article
ISSN
0146-6615

No coin nor oath required. For personal study only.

✦ Synopsis

Nineteen healthy young adults were vaccinated with plasma-derived hepatitis B vaccine at months 0, 1, and 12, and their immune responses were compared to those of a similar group of 20 vaccinees immunized at months 0, 1, and 6. Late booster injections at 12 months produced nearly fivefold higher geometric mean anti-HBs levels than those of the control group. The higher anti-HBs values may lead to longer persistence of anti-HBs and thus to longer protection against hepatitis B.

πŸ“œ SIMILAR VOLUMES

Very low dose hepatitis B vaccination in
Very low dose hepatitis B vaccination in the newborn: Anamnestic response to booster at four years
✍ Dr. C. D. Moyes; A. Milne; J. Waldon πŸ“‚ Article πŸ“… 1990 πŸ› John Wiley and Sons 🌐 English βš– 236 KB

## Abstract Seventy‐eight children who had received three very low doses (1 or 2 ΞΌg) of Merck, Sharp, and Dohme (MSD) plasma‐derived vaccine (PDV) in early infancy were followed to approximately four years of age. Of the 70 who had responded to the initial course of vaccine with measurable anti‐HBs

Long-term response to hepatitis B vaccin
Long-term response to hepatitis B vaccination and response to booster in children born to mothers with hepatitis B e antigen
✍ Li-Min Huang; Bor-Luen Chiang; Chin-Yun Lee; Ping-Ing Lee; Wei-Kuang Chi; Mei-Hw πŸ“‚ Article πŸ“… 1999 πŸ› John Wiley and Sons 🌐 English βš– 66 KB πŸ‘ 2 views

Hepatitis B (HB) vaccine provides an uncertain duration of protection and the optimal timing of booster vaccine remains unclear. This study examined the immune response at 10 years of 118 children who had developed protective anti-HB surface (anti-HBs) levels after a primary series of HB immunizatio

The immune response of healthy nigerian
The immune response of healthy nigerian adults to small doses of hepatitis B vaccine: Comparison of 10- and 20-ΞΌg doses
✍ E. A. Ayoola πŸ“‚ Article πŸ“… 1984 πŸ› John Wiley and Sons 🌐 English βš– 174 KB

The immunogenic effect of hepatitis B vaccine (H-B-vax) was evaluated in 120 seronegative healthy Nigerians. Three doses of the vaccine were given at 0, 1, and 6 months. Serial blood samples were tested I month after each vaccination for hepatitis B surface antibody (anti-HBs) and antibody to hepati

Characterization of a human monoclonal a
Characterization of a human monoclonal antibody obtained after immunization with plasma vaccine and a booster with recombinant-DNA hepatitis B vaccine
✍ R.A. Heijtink; J. Kruining; P. van Bergen; S. de Rave; J. van Hattum; M. Schutte πŸ“‚ Article πŸ“… 2002 πŸ› John Wiley and Sons 🌐 English βš– 204 KB

A human monoclonal antibody type IgG4, designated 1Ff4, was obtained by Epstein Barr virus transformation of peripheral blood lymphocytes from a hepatitis B vaccinee (HB-VAX: plasmaderived vaccine) after one boost of yeast recombinant DNA derived vaccine (Engerix-B). 1Ff4 binds preferentially to HBs